The conversation around cardiometabolic health is changing. It is moving from episodic treatment to continuous, behavior-driven management.
At Frontiers Health 2025 in Berlin, we saw this shift firsthand during the deep-dive panel on reshaping the management of obesity and weight-related conditions. We were proud to have our own Silja-Riin Voolma, Ph.D. (Cantab), Strategy & Growth Lead at Newel Health, represent our vision alongside some of the industry’s most forward-thinking leaders.
A Meeting of Minds
Brilliantly hosted by Megan Coder (Society for Digital Mental Health), the panel brought together a diverse group of innovators representing the full spectrum of the ecosystem—from digital therapeutics to pharma and supply chain.
Silja-Riin was joined on stage by:
- Jim O’Donoghue (S3 Connected Health)
- Saemundur Oddsson, MD (Sidekick Health)
- Mithun Ratnakumar (Gerresheimer)
- Björn Thorngren (Meds.se)
Key Themes: Beyond the Pill
The discussion confirmed what we at Newel Health have long believed: technology, data, and behavioral science must converge.
As noted by attendees and panelists alike, the challenge in cardiometabolic health—particularly with the rise of GLP-1 medications—is not just about access to drugs. It is about creating smarter, more personalized, and continuous care models.
The panel explored how we can address the entire patient journey, moving beyond simple disease management to include:
- Prevention: Identifying risks before they become acute.
- Behavioral Reinforcement: Using digital tools to support the lifestyle changes necessary for long-term weight management.
- Sustainability: ensuring that interventions remain effective long after the initial prescription.
The Ecosystem Approach
One of the most inspiring takeaways from the session was the spirit of collaboration. The consensus in the room was clear: innovation is scaling because pharma, medtech, and digital innovators are finally speaking the same language.
From connected medtech devices that track vitals in real-time to digital health ecosystems that provide psychological support, we are seeing a holistic safety net being built around the patient.
The Bottom Line
As one attendee perfectly summarized: “Innovation in health isn’t just about new tools — it’s about integrating care, empowering patients, and making health sustainable.”
At Newel Health, we are committed to playing our part in that sustainability. Whether through our H. Core platform or our specific therapeutic verticals, we will continue to champion the role of behavioral science in the cardiometabolic revolution.
Thank you to everyone who attended the session and contributed to this vital dialogue.
